Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Jul 19;8(9):526-38.
doi: 10.1038/nrcardio.2011.104.

Treatment of pulmonary arterial hypertension with targeted therapies

Affiliations
Review

Treatment of pulmonary arterial hypertension with targeted therapies

Dermot S O'Callaghan et al. Nat Rev Cardiol. .

Abstract

Pulmonary arterial hypertension (PAH) is a rare disorder characterized by progressive obliteration of the pulmonary microvasculature that results in elevated pulmonary vascular resistance and premature death. Although no cure exists for PAH, improved understanding of the pathobiological mechanisms of this disease has resulted in the development of effective therapies that target specific aberrant pathways. Agents that modulate abnormalities in the prostacyclin, endothelin, and nitric oxide pathways have been shown in randomized, controlled studies to confer improvements in functional status, pulmonary hemodynamics, and possibly even slow disease progression. Several additional pathways believed to play an important role in the pathogenesis of PAH have been identified as potentially useful therapeutic targets and a number of investigative approaches focusing on these targets are in active development. In this Review, we highlight the pharmacological agents currently available for the treatment of PAH and discuss potential novel strategies.

PubMed Disclaimer

References

    1. Chest. 2011 Nov;140(5):1274-1283 - PubMed
    1. N Engl J Med. 1992 Jul 9;327(2):70-5 - PubMed
    1. Am J Respir Crit Care Med. 2009 Jun 15;179(12):1151-8 - PubMed
    1. Am J Respir Crit Care Med. 2005 Dec 15;172(12):1586-9 - PubMed
    1. Eur Respir J. 2010 Sep;36(3):549-55 - PubMed

MeSH terms

Substances